Association Between Platelet Count and Postoperative Blood Loss in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass and Fresh Frozen Plasma Administration Guided by Thromboelastometry.

BACKGROUND Coagulopathy after cardiopulmonary bypass (CPB) is caused by multiple factors, including reduced coagulation factors and a low platelet count.Methods and Results:In this study, we undertook a post hoc analysis to identify factors associated with increased postoperative blood loss in 97 patients undergoing cardiac surgery with CPB, with fresh frozen plasma administered according to a ROTEM-guided algorithm. We identified 24 patients for the top quartile of postoperative blood loss, >528 mL and defined as having excessive blood loss. Using Spearman's rank correlation test and multivariable linear regression, we reanalyzed the participants' demographic, surgical and anesthetic variables, laboratory test results, blood loss, and transfusion data. Univariate analysis indicated that patients who experienced higher postoperative blood loss received a significantly higher heparin dose, had a higher requirement for fresh frozen plasma transfusion during surgery, and had a significantly lower hematocrit and platelet count at the end of surgery compared with patients without excessive blood loss. Multivariate analysis showed that platelet count at the end of surgery (odds ratio 0.780, 95% confidence interval 0.629-0.967; P=0.024) was an independent factor for excessive blood loss. CONCLUSIONS Low platelet count at the end of surgery was associated with excessive postoperative bleeding during cardiac surgery with CPB.

[1]  H. Schöchl,et al.  Assessing the Methodology for Calculating Platelet Contribution to Clot Strength (Platelet Component) in Thromboelastometry and Thrombelastography , 2015, Anesthesia and analgesia.

[2]  B. Romlin,et al.  Platelet count and function in paediatric cardiac surgery: a prospective observational study. , 2014, British journal of anaesthesia.

[3]  M. Ozaki,et al.  Reappearance of circulating heparin in whole blood heparin concentration-based management does not correlate with postoperative bleeding after cardiac surgery. , 2014, Journal of cardiothoracic and vascular anesthesia.

[4]  P. Nelemans,et al.  Rapid and correct prediction of thrombocytopenia and hypofibrinogenemia with rotational thromboelastometry in cardiac surgery. , 2014, Journal of cardiothoracic and vascular anesthesia.

[5]  J. Dinardo,et al.  TEG and ROTEM: Technology and clinical applications , 2014, American journal of hematology.

[6]  S. McCluskey,et al.  Platelet Dysfunction as Measured by a Point-of-Care Monitor is an Independent Predictor of High Blood Loss in Cardiac Surgery , 2014, Anesthesia and analgesia.

[7]  W. Beattie,et al.  The Relationship Between Fibrinogen Levels After Cardiopulmonary Bypass and Large Volume Red Cell Transfusion in Cardiac Surgery: An Observational Study , 2013, Anesthesia and analgesia.

[8]  J. Maessen,et al.  Preoperative thrombin generation is predictive for the risk of blood loss after cardiac surgery: a research article , 2013, Journal of Cardiothoracic Surgery.

[9]  P. Wouters,et al.  Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. , 2013, European journal of anaesthesiology.

[10]  M. Milošević,et al.  Bleeding risk assessment using whole blood impedance aggregometry and rotational thromboelastometry in patients following cardiac surgery , 2013, Journal of Thrombosis and Thrombolysis.

[11]  N. Weitzel,et al.  Platelet mapping as part of modified thromboelastography (TEG®) in patients undergoing cardiac surgery and cardiopulmonary bypass , 2012, Anaesthesia.

[12]  S. Body,et al.  Does Rotational Thromboelastometry (ROTEM) Improve Prediction of Bleeding After Cardiac Surgery? , 2012, Anesthesia and analgesia.

[13]  S. Ostrowski,et al.  Coagulopathy and hemostatic monitoring in cardiac surgery: An update , 2012, Scandinavian cardiovascular journal : SCJ.

[14]  Kenichi A. Tanaka,et al.  Fibrinogen and Hemostasis: A Primary Hemostatic Target for the Management of Acquired Bleeding , 2012, Anesthesia and analgesia.

[15]  A. Hanke,et al.  First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. , 2011, Anesthesiology.

[16]  P. Collins,et al.  Assessment of thrombin generation measured before and after cardiopulmonary bypass surgery and its association with postoperative bleeding , 2011, Journal of thrombosis and haemostasis : JTH.

[17]  A. Civelek,et al.  Thromboelastography‐Based Transfusion Algorithm Reduces Blood Product Use after Elective CABG: A Prospective Randomized Study , 2009, Journal of cardiac surgery.

[18]  R. Doğan,et al.  Preoperative fibrinogen levels as a predictor of postoperative bleeding after open heart surgery. , 2007, The heart surgery forum.

[19]  G. White,et al.  The interaction of thrombin with blood platelets , 2005, Platelets.

[20]  W. Chandler.  Effects of hemodilution, blood loss, and consumption on hemostatic factor levels during cardiopulmonary bypass. , 2005, Journal of cardiothoracic and vascular anesthesia.

[21]  Harold A Scheraga,et al.  The thrombin-fibrinogen interaction. , 2004, Biophysical chemistry.

[22]  A.,et al.  Bleeding Complications Associated With Cardiopulmonary Bypass , 2003 .

[23]  H. Kojima,et al.  Low-dose protamine based on heparin-protamine titration method reduces platelet dysfunction after cardiopulmonary bypass. , 1999, The Journal of thoracic and cardiovascular surgery.

[24]  M. DePerio,et al.  Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. , 1999, Anesthesia and analgesia.

[25]  D. Jobes,et al.  Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations. , 1995, The Journal of thoracic and cardiovascular surgery.

[26]  E. Spitznagel,et al.  The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation. , 1995, The Journal of thoracic and cardiovascular surgery.

[27]  J. Torbet.  The Thrombin Activation Pathway Modulates the Assembly, Structure and Lysis of Human Plasma Clots In Vitro , 1995, Thrombosis and Haemostasis.

[28]  J. Hirsh,et al.  Heparin Binding Proteins Contribution to Heparin Rebound After Cardiopulmonary Bypass , 1993, Circulation.

[29]  J. Hirsh,et al.  Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. , 1992, Chest.

[30]  S. Khuri,et al.  Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss. , 1992, The Journal of thoracic and cardiovascular surgery.

[31]  R. Hillman,et al.  Platelet activation and aggregation during cardiopulmonary bypass. , 1991, Anesthesiology.

[32]  S. Gundry,et al.  Postoperative bleeding in cardiovascular surgery. Does heparin rebound really exist? , 1989, The American surgeon.

[33]  J. Caprini,et al.  Decreased Platelet Number and Function and Increased Fibrinolysis Contribute to Postoperative Bleeding in Cardiopulmonary Bypass Patients , 1988, Thrombosis and Haemostasis.

[34]  T. Wakefield,et al.  Depressed cardiovascular function and altered platelet kinetics following protamine sulfate reversal of heparin activity. , 1984, Journal of vascular surgery.

[35]  Y. Miyauchi,et al.  Quantitative and functional changes in platelets and their preservation during extracorporeal circulation. , 1982, The Journal of cardiovascular surgery.

[36]  A. Montoya,et al.  Management of postoperative heparin rebound following cardiopulmonary bypass. , 1981, The Journal of thoracic and cardiovascular surgery.

[37]  E. Hessel,et al.  Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha-granule release. , 1980, Blood.

[38]  N. Ellison,et al.  Heparin rebound. Studies in patients and volunteers. , 1974, The Journal of thoracic and cardiovascular surgery.